We believe in a world where everyone, regardless of their country’s wealth or frontiers, has access to medicines and healthcare when they need it
We work everyday to remove key barriers that patients in Low- and Middle-Income countries (LMICs) face in their quest to access quality healthcare at the point of need
Establish economic long-term partnership through a membership model with LMIC healthcare players interested in lowering drug prices (health providers, NGOs, FBOs, IOs, etc.)
AxmedRx aggregates demand via its trusted proprietary platform, negotiates lower prices, curates consolidated RFPs for Pharma manufacturers to supply off-patent and patented drugs, and maps supply logistics.
Members commit to a fixed portion of annual procurement through AxmedRx, utilizing our demand aggregation medicine marketplace platform.
A fixed margin percentage is applied to supplied products, with a significant proportion redeployed through partners towards addressing health systems infrastructure gaps
As a not-for-profit organization, we leverage the healthcare utility model and work closely with the public and private sector to bridge the access gap between Quality Medicines manufacturers' focus on hiigh incomes markets and lmic's for best-in-class therapies
Lorem ipsum
Lorem ipsum
Lorem ipsum
Establish economic long-term partnership through a membership model with LMIC healthcare players interested in lowering drug prices (health providers, NGOs, FBOs, IOs, etc.)
AxmedRx aggregates demand via its trusted proprietary platform, negotiates lower prices, curates consolidated RFPs for Pharma manufacturers to supply off-patent and patented drugs, and maps supply logistics.
Members commit to a fixed portion of annual procurement through AxmedRx, utilizing our demand aggregation medicine marketplace platform.
A fixed margin percentage is applied to supplied products, with a significant proportion redeployed through partners towards addressing health systems infrastructure gaps
Our Portfolio
Within the CRM therapeutic area, AxmedRx covers three main disease areas that address the largest burdens of disease across LMICs
Within the Oncology therapeutic area, AxmedRx covers five main disease areas that address the largest burdens of disease across LMICs:
Within our programmatic portfolio, we will initially focus on Sickle Cell Disease.
WHAT VALUE WE OFFER TO OUR PARTNERS
The 2022 Access to Medicine Index finds that since the COVID-19 pandemic hit, more pharmaceutical companies have stepped up to make some...
Patients in the developing world often face prices for essential medicines far in excess of international reference levels, even if those drugs have lost...
The Covid-19 pandemic underscored the urgent need for equitable access to medicine. But when it comes to expanding access, the pivotal role...
© 2023 | All Rights Reserved | Powered by Globiz Technology Inc.
